Two PharmExtracta’s Finalists at NutraIngredients Awards Europe 2025

We’re proud to announce that iNatal® and Meloff® and have been selected as finalists at the NutraIngredients Awards Europe 2025. These nominations highlight our ongoing commitment to advancing science-backed solutions in women’s health and microbiome support.
Join us at Vitafoods Europe in Barcelona, Stand 3B6 from May 20–22, and discover these and other innovative products that could represent valuable opportunities for your market.

PharmExtracta continues its journey of innovation and excellence

We are proud to announce that two PharmExtracta products have been selected as finalists for the prestigious NutraIngredients Awards Europe 2025. This recognition reaffirms our dedication to creating targeted, scientifically validated nutraceutical solutions that respond to real health needs.

  • iNatal® – Finalist for Microbiome Modulation Product of the Year
  • Meloff® – Finalist for Botanical Product of the Year


These nominations reflect our unwavering commitment to combining pharmaceutical-grade quality with the most advanced research in the field of nutraceuticals.

iNatal®: Precision Probiotic Support During Pregnancy

iNatal® is a clinically backed probiotic supplement developed to reduce genitourinary infections and improve pregnancy outcomes through targeted microbiota modulation.

Its exclusive combination of probiotic strains includes:

  • Enterococcus faecium L3 – combats E. coli, Klebsiella, and Proteus, reduces intestinal permeability
  • Bifidobacterium animalis subsp. lactis BB-12® – strengthens the gut barrier and reduces inflammation
  • Lacticaseibacillus casei R0215 and Lactococcus lactis SP38 – alleviate IBS symptoms and bloating


Clinical studies have demonstrated:

  • A 67% reduction in premature rupture of membranes (PROM)
  • A 33% reduction in Group B Streptococcus (GBS) positivity
  • A 23% reduction in antibiotic usage during pregnancy
  • Fewer cesarean sections and intestinal disorders in treated groups


Delivered in single-dose sachets that dissolve in water, iNatal® offers ease of use, excellent compliance, and proven benefits throughout pregnancy. Moreover, it is widely trusted by gynecologists and midwives across Italy.

Meloff®: Naturally Restoring Deep Sleep

Meloff® is a botanical supplement based on Melissa officinalis Phytosome® (Relissa®), a clinically proven formulation that promotes restful, restorative sleep without side effects or morning drowsiness.

Thanks to the Phytosome® delivery system, Relissa® offers enhanced bioavailability of rosmarinic acid, which increases GABA levels through inhibition of GABA transaminase (GABA-T). This action improves sleep architecture and quality.

Key clinical outcomes include:

  • 87% of users reported improved sleep quality, versus only 30% in the placebo group
  • A 30% reduction in Insomnia Severity Index (ISI) scores
  • A 15% increase in deep sleep (slow-wave sleep) – the most restorative sleep stage
  • No reported side effects or daytime fatigue


For more details on this trial and the rigorous study design behind it I invite you to read our past article on Meloff®

With a dual mechanism of action—modulating neurotransmitters and reducing oxidative stress—Meloff® stands out as an innovative, effective, and well-tolerated solution for individuals suffering from sleep disruption.

Join Us at Vitafoods Europe 2025 in Barcelona

We warmly invite you to meet us at Vitafoods Europe 2025, taking place in the vibrant city of Barcelona from May 20–22 at Fira Barcelona Gran Via.

Come visit our stand to discover how iNatal® and Meloff® are setting new standards in the field of microbiome modulation and botanical supplements. You’ll have the chance to explore the science behind our formulations and engage with our team of experts.

📍 Fira Barcelona Gran Via – Av. Joan Carles I, 64, L’Hospitalet de Llobregat
📅 May 20–22, 2025
🎯 Stand 3B6

Together, let’s advance the future of nutraceutical innovation.

iNatal Meloff